VorugantiLCorteseLOwyeumiLKottedaVCernovskyZZirulS, Switching from conventional to novel antipsychotic drugs: results of a prospective naturalistic study. Schizophr Res2002; 57: 201–8.
2.
KanedaYImakuraAFujiiAOhmoriT. The Schizophrenia Quality of Life Scale: validation of the Japanese version. Psychiatry Res2002; 113: 100–6.
3.
InadaT. [Evaluation and diagnosis of drug-induced extrapyramidal symptoms: commentary on the DIEPSS and guide to its usage] Japanese. Tokyo: Seiwa Pub., 1996.
4.
GreenMFKernRSBraffDLMintzJ. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the “right stuff”?Schizophr Bull2000; 26: 119–36.
5.
DrachmanDA. Memory and cognitive function in man: does the cholinergic system have a specific role?Neurology1977; 27: 783–90.